Rare cancers: a sea of opportunity.

Abstract excerpt

Rare cancers, as a collective, account for around a quarter of all cancer diagnoses and deaths. Historically, they have been divided into two groups: cancers defined by their unusual histogenesis (cell of origin or differentiation state)--including chordomas or adult granulosa cell tumours--and histologically defined subtypes of common cancers. Most tumour types in the first group are still clinically and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genomics
• Share to Immunotherapy
• Share to Molecular Targeted Therapy